StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories geographic Revenue — China ($M) ($M)

Postgres DB segment_values + Form 10-K Geographic Footnote

Latest, FY2025
1,907
Period ended Dec 31, 2025
Change on a year earlier
-9.7%
2,113 in FY2024
History
15 years
Since FY2011
Sources
13
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGeographic Revenue — China ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,907-9.7%Form 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 20242,113-6.2%Form 10-K (filed 2025-02-21) ↗
FY2023Dec 31, 20232,253+5.6%Form 10-K (filed 2024-02-16) ↗
FY2022Dec 31, 20222,133-10.8%Form 10-K (filed 2023-02-17) ↗
FY2021Dec 31, 20212,392+21.7%Form 10-K (filed 2022-02-18) ↗
FY2020Dec 31, 20201,965-16.2%Form 10-K (filed 2021-02-19) ↗
FY2019Dec 31, 20192,346+1.5%Form 10-K (filed 2020-02-21) ↗
FY2018Dec 31, 20182,311+7.7%Form 10-K (filed 2019-02-22) ↗
FY2017Dec 31, 20172,146+24.2%Form 10-K (filed 2018-02-16) ↗
FY2016Dec 31, 20161,728-3.8%Form 10-K (filed 2017-02-17) ↗
FY2015Dec 31, 20151,796+36.0%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 20141,321+22.0%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 20131,083+26.1%Form 10-K (filed 2014-02-21) ↗
FY2012Dec 31, 2012859+37.4%Form 10-K (filed 2014-02-21) ↗
FY2011Dec 31, 2011625–Form 10-K (filed 2014-02-21) ↗

Cite this data

StockData. (2026). Abbott Laboratories Geographic Revenue — China ($M) ($M), annual FY2011–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-geo-cn

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.